Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhengkang Luo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|July 24, 2023
Diabetic complications and prospective immunotherapyLewis Reynolds, Zhengkang Luo, Kailash Singh
International Journal of Molecular Sciences|July 27, 2022
Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 DiabetesZhengkang Luo, Charlotte Soläng, Rasmus Larsson, et al.
Journal of Visualized Experiments : Jove|March 19, 2019
Determination of Regulatory T Cell Subsets in Murine Thymus, Pancreatic Draining Lymph Node and Spleen Using Flow CytometryZhengkang Luo, Lina Thorvaldson, Martin Blixt, et al.
FASEB Bioadvances|March 4, 2020
Kinetics of immune cell responses in the multiple low-dose streptozotocin mouse model of type 1 diabetesZhengkang Luo, Charlotte Soläng, Mariela Mejia-Cordova, et al.
Endocrine|February 29, 2024
Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetesZhengkang Luo, Mariela Mejia-Cordova, Nour Hamze, et al.
Oncotarget|May 4, 2018
Pro-tumoral immune cell alterations in wild type and <i>Shb</i>-deficient mice in response to 4T1 breast carcinomasXiujuan Li, Kailash Singh, Zhengkang Luo, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2023
Design, synthesis and evaluation of heterocyclic 2-phenylacetate derivatives as water-soluble rapid recovery hypnoticsJin Zhu, Xinyi Xiao, Huimin Qin, et al.
Biomolecules|October 27, 2022
Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes DevelopmentKailash Singh, Orian Bricard, Jeason Haughton, et al.
Scientific Reports|May 19, 2019
The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumorsQi He, Xiujuan Li, Kailash Singh, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 7, 2026
AMP deaminase-2- and adenosine deaminase-mediated disposal of β-cell intracellular adenosine protects against multiple low-dose streptozotocin-induced type 1 diabetesKailash Singh, Tongjian Zhao, Anongnad Ngamjariyawat, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|July 24, 2023
Diabetic complications and prospective immunotherapyLewis Reynolds, Zhengkang Luo, Kailash Singh
International Journal of Molecular Sciences|July 27, 2022
Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 DiabetesZhengkang Luo, Charlotte Soläng, Rasmus Larsson, et al.
Journal of Visualized Experiments : Jove|March 19, 2019
Determination of Regulatory T Cell Subsets in Murine Thymus, Pancreatic Draining Lymph Node and Spleen Using Flow CytometryZhengkang Luo, Lina Thorvaldson, Martin Blixt, et al.
FASEB Bioadvances|March 4, 2020
Kinetics of immune cell responses in the multiple low-dose streptozotocin mouse model of type 1 diabetesZhengkang Luo, Charlotte Soläng, Mariela Mejia-Cordova, et al.
Endocrine|February 29, 2024
Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetesZhengkang Luo, Mariela Mejia-Cordova, Nour Hamze, et al.
Oncotarget|May 4, 2018
Pro-tumoral immune cell alterations in wild type and <i>Shb</i>-deficient mice in response to 4T1 breast carcinomasXiujuan Li, Kailash Singh, Zhengkang Luo, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2023
Design, synthesis and evaluation of heterocyclic 2-phenylacetate derivatives as water-soluble rapid recovery hypnoticsJin Zhu, Xinyi Xiao, Huimin Qin, et al.
Biomolecules|October 27, 2022
Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes DevelopmentKailash Singh, Orian Bricard, Jeason Haughton, et al.
Scientific Reports|May 19, 2019
The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumorsQi He, Xiujuan Li, Kailash Singh, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 7, 2026
AMP deaminase-2- and adenosine deaminase-mediated disposal of β-cell intracellular adenosine protects against multiple low-dose streptozotocin-induced type 1 diabetesKailash Singh, Tongjian Zhao, Anongnad Ngamjariyawat, et al.
Pageof 2